Management of Peripheral Neuropathy Associated with Brentuximab Vedotin in cHL

IMPACT Medicom
26/03/2025 19 min
Management of Peripheral Neuropathy Associated with Brentuximab Vedotin in cHL

Listen "Management of Peripheral Neuropathy Associated with Brentuximab Vedotin in cHL"

Descargar episodio

Episode Synopsis

In this podcast episode, Dr. Michael Chu discusses the management of peripheral neuropathy associated with the use of brentuximab vedotin for the first-line treatment of classical Hodgkin Lymphoma. Our GuestDr. Michael Chu is a clinician scientist at the Cross Cancer Institute and an Associate Professor at the University of Alberta in Edmonton, Alberta.This podcast episode was sponsored by Pfizer Canada Inc.If you enjoyed our podcast episode, please review and subscribe. For other medical education content, visit our website at: https://www.impactmedicom.com (https://www.impactmedicom.com/).

More episodes of the podcast IMPACT Medicom

Thoracic Surgery Series: Resection after Neoadjuvant Immunotherapy 10/11/2025
Highlights from EHA/ICML 2025: International Perspective on CLL 26/06/2025
Prise en charge de la PN associée au BV utilisé pour le traitement de première intention du cH 27/03/2025
ASH 2024: Updates on CLL 29/12/2024
Integrating Non-Covalent BTK Inhibitors in CLL: Navigating a Rapidly Evolving Treatment Landscape 04/09/2024
Highlights from EHA 2024 - Updates on the Treatment of CLL 02/07/2024
LIVE FROM EHA 2024 - Sonrotoclax plus Zanubrutinib in R/R CLL 21/06/2024
Cutting Edge Advances in the Treatment of Lung Cancer 19/04/2024
Precision Medicine Series: Ep15: Biomarkers in Upper GI Cancers 18/04/2024
Management of Cutaneous Squamous Cell Carcinoma (cSCC): A Surgeon’s Perspective 25/03/2024
© 2003-2025 ZARZA | AHEAD OF OUR TIME
privacy policy
In God we trust In God we trust
PreSales Questions? Click Here
or call our toll-free line at +1-888-5002068 Miami, Florida, USA